ClinicalTrials.govpublic full text
Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma
brain tumor, astrocytoma, astroglioma, glioblastoma, gliosarcoma, relapse, randomized, temodar, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 810782
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.